Cardiff Oncology (CRDF)
(Real Time Quote from BATS)
$2.46 USD
-0.01 (-0.41%)
Updated Oct 2, 2024 09:46 AM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (77 out of 252)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.37 | 9.99 |
Current Quarter Estimate | -0.27 | 3.00 | 63.00 |
Year Ago Quarter Estimate | -0.22 | -4.79 | 52.25 |
Next Quarter Estimate | -0.27 | 3.82 | 66.00 |
Next Year Estimate | -1.05 | 24.58 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -8.60 | 17.80 | 15.67 |
Next Year | -3.96 | 9.50 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -6.95 |
Price/Book (MRQ) | 2.11 | 2.03 |
Price/Cash Flow (MRFY) | NA | 16.44 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -6,143.91% | -163.24% |
Return on Equity (TTM) | -62.65% | -61.40% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.